Anal Cancer
📧 Sign up to get email alerts when something new happens for Anal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes [Phase 2]
A Phase 2 clinical trial evaluating dynamic ctDNA assessment in cervical and anal canal cancers to optimize follow-up and clinical outcomes.…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer
A clinical trial run by Aarhus University Hospital is recruiting to study gynecological and sexual health in women after radiotherapy for an…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab [Phase 1, Phase 2]
Ongoing Phase 1/2 trial evaluating the combination of pelareorep and atezolizumab in advanced anal cancer and pancreatic cancer.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV [NA]
A clinical trial is evaluating concordance and acceptability of self-screening versus clinician-screened HPV swab screening in people living…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) [NA]
The HPV MISTICS clinical trial evaluating multilevel strategies to improve HPV vaccination in community settings has been suspended.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial [NA]
This clinical trial update describes a study to identify molecular signatures of high-risk oncogenic human papillomavirus and to evaluate th…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination [NA]
This clinical trial is evaluating whether sending reminders about HPV vaccination via adolescents' preferred communication methods increases…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis [NA]
This clinical trial assesses screening for anal cancer and precancerous anal lesions in men who have sex with men on pre-exposure prophylaxi…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Efficacy and Safety of the CG-100 Intraluminal Bypass Device [NA]
The document provides a trial update for the CG-100 intraluminal bypass device, noting that recruitment is ongoing for rectal cancer-related…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy [NA]
This clinical study evaluates a chatbot designed to improve confidence in the HPV vaccine and reduce hesitancy; the trial is not yet recruit…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students [Phase 4]
Phase 4 clinical trial update showing six-year persistence of immune response after a single dose of the 9-valent HPV vaccine in male and fe…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Blood Biomarkers Based Screening for HPV-driven OPC [NA]
UNICANCER-sponsored trial is evaluating blood biomarker-based screening for HPV-driven cancers, including oropharyngeal cancer, with status …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Deciphering Mechanisms Underlying Cancer Immunogenicity [NA]
A clinical trial exploring mechanisms underlying cancer immunogenicity, sponsored by Institut Claudius Regaud; the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Screening Strategies Among High-risk Populations for Anal Cancer [NA]
This clinical trial update reports a study evaluating screening strategies for high-risk populations to detect anal cancer, including HPV-re…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: HPV Vaccine Reminders - SEARCH II Study [NA]
This clinical trial update summarizes the SEARCH II study on using reminders to improve uptake of the human papillomavirus vaccine; the tria…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA [Phase 3]
A Phase III trial is evaluating induction chemotherapy followed by chemoradiotherapy versus standard chemoradiotherapy for locally advanced …
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).
This clinical trial evaluates patient-reported outcomes in anal cancer patients treated with intensity-modulated radiotherapy (IMRT) and is …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Screening Women With Prior HPV for Anal Neoplasia [NA]
An ongoing recruiting clinical trial from Icahn School of Medicine at Mount Sinai aims to screen women with prior HPV for anal neoplasia and…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: HPV Vaccine Reduced Dose [Phase 4]
Phase 4 trial from Emory University evaluating a reduced-dose human papillomavirus vaccine; recruitment is ongoing for HPV-related indicatio…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Stigma and Psychological profilE in REctal-anal caNcer pAtients
A clinical trial assessing stigma and psychological profiles in patients with rectal or anal cancer is currently recruiting. The study is sp…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers [Phase 1]
Phase 1 clinical trial examining the biodistribution of the Ga-68 labeled imaging tracer 68Ga-FAPi-46 in patients with solid tumors and hema…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial [NA]
A clinical trial update describes TweenVax, an Emory University vaccine to improve adolescent HPV vaccination, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
A University of Minnesota-sponsored clinical trial is currently recruiting to assess anal cancer prevention strategies in gay men. The study…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males [Phase 3]
Phase III trial evaluating the efficacy, immunogenicity, and safety of a recombinant HPV9-valent vaccine in Chinese males for prevention of …